NRBO - Margin dodolan resik NeuroBo Pharmaceuticals, Inc.

NRBO (NeuroBo Pharmaceuticals, Inc.) - tandha merek perusahaan

Actual net profit margins demonstrate the scaling potential of NeuroBo Pharmaceuticals (NRBO) driven by a patent monopoly and low drug synthesis costs. A lean team of scientists and support from an Asian partner ensure the stability of the R&D core. The 0.00 level is recording fresh values amid DA-1726 trials and high demand for MASH and obesity therapies.

Tingkat bathi resik NeuroBo Pharmaceuticals (NRBO): kanggo periode 04.07.2022 - 07.12.2024

NRBO (NeuroBo): rincian analitis lan laporan miturut indikator

Analisis dhasar perusahaan:NeuroBo Pharma - NRBO
Barang unggulan NeuroBo Pharmaceuticals Inc

The investment attractiveness of NeuroBo Pharmaceuticals (NRBO) is based on the potential of its metabolic disorder therapies. This metric determines the share of net profit in total revenue, assessing the ultimate efficiency of cost management. Analyzing the net margin allows for the filtering of temporary fluctuations to identify the real momentum of profitability. For this obesity drug developer, this trend reflects the balance between R&D expenditures and financial returns. The steady growth of the line confirms the fundamental stability of the business model.

Analisis perusahaan pesaing

BIIB: Margin dodolan resik|Margin resik Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Margin dodolan resik|AXSM: Tingkat bathi resik|Margin resik acadia-pharm.com (ACAD)|Margin dodolan resik Xenon Pharmaceuticals (XENE)|Margin resik Viking Therapeutics VKTX|Tingkat bathi resik SUPN|CPRX - Margin resik|Margin resik Denali Therapeutics|HRMY: Margin dodolan resik|Biohaven - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik AMLX|Trevi Therapeutics, Inc. (TRVI) - Margin dodolan perusahaan|Rentabilitas dodolan miturut bathi resik PRAX (Praxis Medicines)|Anavex Corp - Rentabilitas dodolan resik|Margin resik CeriBell CBLL|Margin dodolan perusahaan Prothena Biosciences (PRTA)|ALEC: Rentabilitas dodolan miturut bathi resik|ANNX - Margin dodolan resik|Omeros Corp. (OMER) - Margin resik|Margin resik Neurogene Inc. (NGNE)|Rentabilitas dodolan miturut bathi resik ACIU|Margin resik VYGR|Margin resik Neumora (NMRA)|SCLX - Margin resik|Margin dodolan resik TVGN (Tevogen Bio Holdings Inc.)|Tingkat bathi resik ACOG|Cognition Therapeutics Inc. - Margin dodolan resik|IKT - Margin dodolan resik|SAVA: Margin dodolan resik|Assertio Holdings, Inc. - Tingkat bathi resik|COYA (Coya) - Margin dodolan resik|Rentabilitas dodolan resik VTGN (Vistagen Therapeutics)|Margin resik Ovid Rx (OVID)|Acumen Pharmaceuticals - Rentabilitas dodolan resik|Margin resik CervoMed, Inc. CRVO|Margin dodolan resik Alterity Therapeutics ATHE|CLNN: Rentabilitas dodolan miturut bathi resik|PEPG (pepgen.com) - Rentabilitas dodolan resik|Jupiter Neurosciences Inc (JUNS) - Margin resik|Relmada Therapeutics - Tingkat bathi resik|ANVS (Annovis Bio Inc) - Margin dodolan resik|GRCE: Tingkat bathi resik|Margin resik Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Tingkat bathi resik|Margin resik neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Margin resik|MTVA: Rentabilitas dodolan miturut bathi resik|NeurAxis, Inc (NRXS) - Rentabilitas dodolan miturut bathi resik|HSDT: Margin dodolan resik|PASG - Margin dodolan perusahaan|Margin resik Neuphoria Therapeutics, Inc.|Margin resik NERV|Margin dodolan resik ATHA|ADXN (Addex Therapeutics Ltd) - Tingkat bathi resik|Margin resik alzamend.com ALZN|Margin dodolan perusahaan Cyclerion Therapeutics (CYCN)|Protagenic - Margin dodolan resik|Tingkat bathi resik KTTA (Pasithea Therapeutics Corp)|CRGT: Margin dodolan resik|Avenue Therapeutics Inc. (ATXI) - Margin dodolan resik|BCLI (BrainStorm Cell Therapeutics Inc.) - Margin dodolan resik|Margin dodolan resik Cara Therapeutics Inc|Margin resik Chromocell Therapeutics (CHRO)|Rentabilitas resik perusahaan ELYM|Margin resik Intra-Cellular ITCI|LBPH: Rentabilitas dodolan resik|MRNS - Margin resik|NKGen Biotech, Inc. (NKGN) - Rentabilitas dodolan miturut bathi resik|SAGE (Sage Therapeutics, Inc) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan resik SNPX|Rentabilitas dodolan miturut bathi resik TRVN|Margin resik VIGL|Margin dodolan resik WENA|Margin dodolan perusahaan Cerevel